Stanford Graduate School of Business (USA)
-
Nuria Chinchilla: el poder de cambiar la empresa
Apfeffer, Jeffrey; Anderson, Megan ElisabethCase SGSB-OB67ESStrategyEn 1993, Nuria Chinchilla había completado recientemente su tesis doctoral en IESE Business School en Barcelona, sobre el tema de la rotación organizacional, sin un enfoque particular en las mujeres, los arreglos laborales flexibles o los problemas laborales. Ella eligió permanecer en el IESE, donde había trabajado desde principios de la década de 1980 como profesora asistente. Para el año 2003, poco más de una década después, había alcanzado e...Starting at €8.20
-
Facebook: Hard Questions (A)
Shotts, Ken; Malhotra, Neil; Melvin, SheilaCase SGSB-ETH15A-EDecision AnalysisIn April 2018, Facebook co-founder and CEO Mark Zuckerberg was called to Capitol Hill to be the star witness at congressional hearings intended to examine Facebook’s “breaches of trust” with its users and “larger questions about the fundamental relationship tech companies have with their users.” Zuckerberg admitted that his company faced “a number of important issues around privacy, safety, and democracy” but emphasized that his company was “idea...Starting at €8.20
-
The Role of Physicians in Device Innovation: Critical Success Factor or Conflict of Interest
Zenioa S; Burns L; Denend LCase SGSB-OIT105-EInformation Technologies, Service and Operations ManagementAs of 2012, the Physician Payments Sunshine Act of 2009 requires medical device manufacturers to track any payments or gifts they make to physicians that are worth more than $10 and then starting in 2013 to report those that exceed a total of $100 per year to any given doctor. While a majority of doctors, academic medical centers, and pharmaceutical and device companies generally support the principle of greater transparency when it comes to phys...Starting at €8.20
-
The Opioid Epidemic (B): Responses to the Crisis
Shotts, Ken; Melvin, SheilaCase SGSB-ETH18B-EDecision AnalysisBetween 1999 and 2017, almost 400,000 Americans died from an opioid overdose. An average of 130 died each day in 2017, six times the daily rate in 1999. These deaths were caused by both prescription opioids and illegal opioids like heroin and illicitly manufactured fentanyl, or IMF. The most common drugs involved in prescription opioid overdose deaths were methadone, oxycodone (like OxyContin), and hydrocodone (like Vicodin). The A case, which ...Starting at €5.74
-
Meta and Political Speech
Shotts, Ken; Melvin, SheilaCase SGSB-ETH34-EDecision AnalysisBy 2022, Meta was the world’s largest social media company, with around 3 billion users sharing 140 billion messages and a billion stories a day. Over 200 million businesses used Meta apps like Facebook, Instagram, and WhatsApp. Meta’s primary source of revenue was advertising. Its proclaimed mission was to “give people the power to build community and bring the world closer together” and its principles were to “give people a voice, build connect...Starting at €8.20
-
Tariffed!
Shotts, Ken; Melvin, SheilaCase SGSB-P94-EEconomicsThis case describes President Donald Trump’s steel and aluminum tariffs of 2018. The case covers the recent history of U.S. trade protectionism in these industries, as well as the domestic and international politics surrounding the Trump tariffs. The case discusses industry reaction to the tariffs, as well as their implementation by the Department of Commerce, and retaliation by other countries.Starting at €8.20
-
The Opioid Epidemic (A)
Shotts, Ken; Melvin, SheilaCase SGSB-ETH-18-EBusiness Ethics and Corporate Social ResponsibilityThis case provides an overview of the history and causes of the U.S. opioid epidemic. It begins with a history of opium and pain management, leading into a description of the current epidemic, its stages, and its scale. The case then presents possible causes of the epidemic: misleading marketing by drug companies, kickback schemes, irresponsible physicians and distributors, lobbying, and societal expectations about eliminating pain.Starting at €8.20